A phase II study of laquinimod in Crohn's disease

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

Stephan R. Targan, Stephen B. Hanauer, Sander J. H. van Deventer et al. · New England Journal of Medicine · 1997 · 3.1K citations · Full text

Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

Daniel H. Present, Paul Rutgeerts, Stephan Targan et al. · New England Journal of Medicine · 1999 · 2.7K citations · Full text

Efficacy and safety of retreatment with anti–tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease

Paul Rutgeerts, Geert D’Haens, Stephan R. Targan et al. · Gastroenterology · 1999 · 1.1K citations · Full text

Inflammation, Chronic Inflammatory Diseases, Anti-inflammatory +5

The Prevalence and Geographic Distribution of Crohn’s Disease and Ulcerative Colitis in the United States

Michael D. Kappelman, Sheryl L. Rifas‐Shiman, Ken Kleinman et al. · Clinical Gastroenterology and Hepatology · 2007 · 922 citations · Full text

Medicine, Gastroenterology, Geographic Distribution +6

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

Geert D’Haens, Marc Ferrante, Séverine Vermeire et al. · Inflammatory Bowel Diseases · 2012 · 797 citations · Full text